Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · IEX Real-Time Price · USD
1.270
-0.010 (-0.78%)
Jul 19, 2024, 4:00 PM EDT - Market closed

CNTB Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019
Selling, General & Admin
14.5214.5220.8119.016.541.33
Research & Development
51.9151.9196.6380.520.6814.58
Other Operating Expenses
-4.35-4.351.88-1.4-0.12-0.81
Operating Expenses
62.0762.07119.3298.1127.0915.1
Operating Income
-62.07-62.07-119.32-98.11-27.09-15.1
Interest Expense / Income
0.020.020.020.010.40.01
Other Expense / Income
-2.71-2.71-1.54103.8979.267.99
Pretax Income
-59.38-59.38-117.79-202-106.75-23.1
Income Tax
0.120.120.30.2700
Net Income
-59.5-59.5-118.09-202.27-106.75-23.1
Shares Outstanding (Basic)
5555575754-
Shares Change
-4.25%-4.15%-0.11%6.57%--
EPS (Basic)
-1.08-1.08-2.15-3.88-6.25-1.37
EPS (Diluted)
-1.08-1.08-2.15-3.88-6.25-1.37
Free Cash Flow
-45.28-45.28-105.93-91.6-24.95-12.51
Free Cash Flow Per Share
-0.82-0.82-1.84-1.59-0.46-
EBITDA
-59.36-59.36-117.77-201.99-106.36-23.09
EBIT
-59.36-59.36-117.77-201.99-106.36-23.09
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).